Continuous Intracranial Pressure Monitoring In The Application Of Hypertension Cerebral Hemorrhage

Objective: In this experiment, through continuous observation on the changes ofintracranial pressure in patients with hypertensive cerebral hemorrhage, to explore theclinical significance of dynamic monitoring of intracranial pressure in the treatment ofhypertensive intracerebral hemorrhage.Methods: Randomly selected in our hospital from2011June to2012June59cases ofhypertensive cerebral hemorrhage patients as the research object. All patients had aclear history of hypertension.(1). Selection criteria::1. Were examined by CT andclinical diagnosis of hypertensive cerebral hemorrhage;2.20ml<V<100ml (volume ofhematoma volume of hematoma is calculated according to the formula).3.GCS3~12分；4. Less than80years of age.(2)Excluded: Fracture trauma, cerebral vascularmalformation, aneurysm, arteriovenous malformation, tumors, stroke and brain stemhemorrhage, With the other organ system implement qualitative sex disease orpregnancy patients Early can’t clear diagnosis, late treatment and diagnosis, but also exit.59patients were randomly divided into A group (N=22) and group B (N=37). Weretreated with basic therapy of two groups of patients after admission, including diet,maintain internal environment balance, parenteral nutrition, hemostatic, nerve nutrition,preventive use of antibiotics etc. The conventional group the empirical use ofmannitol.The treatment group according to the monitoring of intracranial pressurenumerically using mannitol or adjust the treatment program. The two groups wereobserved and compared between mannitol dosage, prognosis, impaired renal function,electrolyte disorder prevalence, incidence of lung infection, stress ulcer. Dynamicanalysis of intracranial pressure monitoring clinical efficacy in the treatment ofhypertensive intracerebral hemorrhage, and to explore its clinical application value. Results: The treatment group of22patients using mannitol average per person(g):：780±75,The incidence of half a year later, according to the GOS score:1.Good in9cases(24.3%),10cases in general(45.5％)，Very poor in3cases(13.6％)Table1;Complication:2patients with electrolyte disorder(9.10%),1cases of renal functionimpairment(4.50％),5cases of stress ulcer(22.7%),6cases of pulmonaryinfection(27.3%),Table2；A control group of37patients using mannitol average per person (g)：1225±125，After half a year according to the GOS disease：Good in9cases (24.3%），Generally12cases （32.4%）,Very poor16cases (43.2%)，Table1;Complication:15patients withelectrolyte disorder(40.5％),10cases of renal function impairment(27.0%),8cases ofstress ulcer(21.6%),10cases of pulmonary infection(27.0%),Table2. Compared withthe treatment group and control group: The amount of dehydratingagent(780±75g):(780±75g)(t=16.72P <0.01);Comparison of the therapeutic effects:24.11：33.50(Z=2.16,P=0.031<<0.05); Comparison of the complications:2:15patientswith electrolyte disorder（9.10%:40.5%),(χ~2=6.65, P<0.05);1:10cases of stressulcer(4.50%:27.0%),(χ~2=4.59, P<0.05), P <0.05，Statistical significance; Electrolyte isdisorder and function damage rate is better than conventional treatment group, The ICPgroup is better than the conventional treatment groupConclusion: For patients with hypertensive cerebral hemorrhage, continuous ICPmonitoring to guide the use of dehydrating agent, reduce the complications, improve theprognosis, is expected to become a new method of treatment...